MicroPort Scientific’s revenue rises up to 14% on strong export growth
Medical device maker MicroPort Scientific Corp. (0853.HK) said on Wednesday its revenue rose between 12% and 14% in the first half of this year, lifted by triple-digit growth for its international business. But its net loss for the period was roughly the same as a year earlier due to high financing costs.
MicroPort Scientific’s forecast would translate to revenue of about $614 million to $625 million for the first half of 2026, compared with $548 million in the first half of 2025. The company said its overseas business was especially strong this year, delivering 140% revenue growth over the six-month period.
The company’s gross margin from continuing operations improved by 3 to 4 percentage points year-on-year during the last period, as it swung to an operating profit of $24 million or more from an operating loss of $13 million a year ago. On its bottom line, the company said it expects to report a net loss from continuing operations for the latest six-month period of up to $50 million, similar to the $49 million net loss it reported a year earlier. It said $43 million in financing costs, combined with several one-time factors, were responsible for the size of the latest loss.
MicroPort Scientific’s stock is down 37% this year.
By Doug Young
To subscribe to Bamboo Works weekly free newsletter, click here
Related Articles
RELATED ARTICLES
-
MicroPort MedBot serves up inaugural profit on booming exports
- Leadrive IPO taps into China’s EV export boom
-
Newborn Town leans on better monetization as user growth slows
9911.HK
- Deepexi unearths deep revenue growth in agentic AI wave
- Huya revenue rises 11% on strong gains for game-related services
-
BRIEF: Sany Heavy’s first-quarter revenue rises 14% as profit growth lags
600031.SHG
-
Uni-President profit rises 9% in first half, as hidden worries linger
0220.HK
